U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C42H51N9O5
Molecular Weight 761.9116
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Rocbrutinib

SMILES

C[C@H]1CN(CCN1C2=CC=C(NC3=NC(=CN(C)C3=O)C4=CC=NC(N5CCN6C(=CC7=C6CC(C)(C)C7)C5=O)=C4CO)C=C2NC(=O)C=C)C8CCOCC8

InChI

InChIKey=OYJVFTNYBWVQHA-SANMLTNESA-N
InChI=1S/C42H51N9O5/c1-6-37(53)45-32-20-28(7-8-34(32)49-14-13-48(23-26(49)2)29-10-17-56-18-11-29)44-38-41(55)47(5)24-33(46-38)30-9-12-43-39(31(30)25-52)51-16-15-50-35(40(51)54)19-27-21-42(3,4)22-36(27)50/h6-9,12,19-20,24,26,29,52H,1,10-11,13-18,21-23,25H2,2-5H3,(H,44,46)(H,45,53)/t26-/m0/s1

HIDE SMILES / InChI

Molecular Formula C42H51N9O5
Molecular Weight 761.9116
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Wed Apr 02 08:42:59 GMT 2025
Edited
by admin
on Wed Apr 02 08:42:59 GMT 2025
Record UNII
KD68L3GRW2
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Rocbrutinib
INN  
Official Name English
2-Propenamide, N-[5-[[6-[2-(1,3,4,6,7,8-hexahydro-7,7-dimethyl-1-oxo-2H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-2-yl)-3-(hydroxymethyl)-4-pyridinyl]-3,4-dihydro-4-methyl-3-oxo-2-pyrazinyl]amino]-2-[(2S)-2-methyl-4-(tetrahydro-2H-pyran-4-yl)-1-piperazinyl]ph
Preferred Name English
rocbrutinib [INN]
Common Name English
N-[5-[[6-[2-(1,3,4,6,7,8-Hexahydro-7,7-dimethyl-1-oxo-2H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-2-yl)-3-(hydroxymethyl)-4-pyridinyl]-3,4-dihydro-4-methyl-3-oxo-2-pyrazinyl]amino]-2-[(2S)-2-methyl-4-(tetrahydro-2H-pyran-4-yl)-1-piperazinyl]phenyl]-2-propena
Systematic Name English
Code System Code Type Description
NCI_THESAURUS
C203033
Created by admin on Wed Apr 02 08:42:59 GMT 2025 , Edited by admin on Wed Apr 02 08:42:59 GMT 2025
PRIMARY
PUBCHEM
139416847
Created by admin on Wed Apr 02 08:42:59 GMT 2025 , Edited by admin on Wed Apr 02 08:42:59 GMT 2025
PRIMARY
SMS_ID
300000051880
Created by admin on Wed Apr 02 08:42:59 GMT 2025 , Edited by admin on Wed Apr 02 08:42:59 GMT 2025
PRIMARY
INN
12658
Created by admin on Wed Apr 02 08:42:59 GMT 2025 , Edited by admin on Wed Apr 02 08:42:59 GMT 2025
PRIMARY
FDA UNII
KD68L3GRW2
Created by admin on Wed Apr 02 08:42:59 GMT 2025 , Edited by admin on Wed Apr 02 08:42:59 GMT 2025
PRIMARY
CAS
2485861-07-0
Created by admin on Wed Apr 02 08:42:59 GMT 2025 , Edited by admin on Wed Apr 02 08:42:59 GMT 2025
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
IN-VITRO
TARGET -> INHIBITOR
IN-VITRO
TARGET -> INHIBITOR
IN-VITRO
Related Record Type Details
ACTIVE MOIETY
LP-168 is an investigational next generation selective Bruton Tyrosine Kinase (BTK) inhibitor that is capable of targeting wild type (WT) BTK irreversibly and C481 mutant BTK (C481S, C481F, and C481R) reversibly